4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001193125-26-083587
Director sold 25,000 shares at $161.11 ($4,027,750)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Coleman Mark Director | 2026-02-26 | Sale 10b5-1 | −25,000 | $161.11 | $4,027,750 | 47,140 | D |
| Open-market sales · 25,000 sh · avg $161.11 · $4,027,750 | |||||||
Loading xslF345X05/ownership.xml…